Celularity Inc. Form 8-K Summary
Business context and reporting period
Celularity Inc. filed a Form 8-K dated March 14, 2023, reporting a Nasdaq continued-listing compliance matter. The filing does not provide operating or financial results for a reporting period.
Key financial metrics and liquidity
The filing does not provide revenue, profit, cash flow, margins, debt, liquidity, or other financial metrics.
Material change versus the prior comparable period
Celularity received a Nasdaq notice that its Class A common stock no longer complied with Nasdaq Listing Rule 5450(a)(1), because the closing bid price remained below $1.00 per share for 30 consecutive business days. The filing does not quantify the stock-price decline or provide a prior-period financial comparison.
Outlook, risks, contingencies, and unusual items
- The notice had no immediate effect on the listing. The Class A common stock continued trading on the Nasdaq Capital Market under the symbol CELU.
- The company had 180 calendar days, through September 11, 2023, to regain compliance.
- Compliance requires a closing bid price of at least $1.00 per share for a minimum of 10 consecutive business days before the deadline.
- If compliance was not restored by September 11, 2023, the company might have been eligible for an additional 180-day grace period, subject to meeting Nasdaq market-value and other initial listing requirements.
- Management stated that it would monitor the closing bid price and evaluate available options, but cautioned that there was no assurance it would regain compliance, obtain an additional grace period, or satisfy other Nasdaq listing requirements.
Important facts for investors to verify
- Whether Celularity regained compliance by September 11, 2023, or received an additional compliance period.
- Whether the company continued to satisfy Nasdaq’s other listing requirements.
- Any subsequent corporate actions intended to address the bid-price deficiency, including a reverse stock split or other capital-market action.
- The company’s financial condition and liquidity, which are not disclosed in this filing.